Whois

Whois / News Briefs

A Short-Term Suspension of GDPR Enforcement on WHOIS May Be Necessary, Says U.S. Government

Implementation of European Union's General Data Protection Regulation, or GDPR, is a major concern of our government, said David Redl during a meeting held on Thursday in Washington DC.

ICANN Releases Temporary WHOIS Specification Plan for GDPR Compliance With Deadline Two Weeks Away

ICANN has released temporary specifications for gTLD registration data in order to establish temporary requirements needed for the organization and gTLD registry operators to continue to comply with existing ICANN contractual requirements and community-developed policies.

ICANN CEO “Cautiously Optimistic” EU to Provide Clear Guidance for Domain Industry GDPR Compliance

"ICANN could invoke emergency powers in its contracts to prevent Whois becoming 'fragmented' after EU privacy laws kick in next month," reports Kevin Murphy in Domain Incite.

ICANN’s GDPR Compliance Model for Whois Unlikely to Be Implemented in Time for May 25 Deadline

Domain name registries and registrars will not be able to implement ICANN's proposed overhaul of the Whois system in time for the EU's General Data Protection Regulation according to an estimated timetable from ICANN.

Dutch Geographic TLDs Refuse Public Access to Whois Data

Organizations behind two of the new geographic top-level domains, .amsterdam and .frl, have refused to provide public access to information about the registrants of domain names, otherwise known as Whois records.

Thick Whois Policy for .COM Goes Live

"The domain name industry is kicking off one of its most fundamental shifts in its plumbing this week," Kevin Murphy reporting in Domain Incite.

U.S. Bypassing ICANN on Whois Privacy With Closed-Door Meeting in Paris

Despite positive discussions currently underway at the ICANN54 meetings in Dublin regarding protection of privacy services for domain name registrants, another meeting in Paris seems to be contradicting the efforts.

ICANN Must Make User Privacy a Central Tenet for New Registrations, Says EFF

In a statement released today, Electronic Frontier Foundation (EFF) has criticized ICANN for not being proactive on privacy matters, saying the organization "can't seem to wrap its head around" the issue.

New Domain Name Registrar Accreditation Agreement Approved by ICANN Board

ICANN Board of Directors today approved a new Domain Name Registrar Accreditation Agreement (RAA) following over a year of negotiations between ICANN and its Registrar Stakeholders Group - last RAA was approved in 2009.

ICANN Board Starts New Initiative to Tackle gTLD Registration Data Challenges

The ICANN Board of Directors has directed the Chief Executive Officer to launch a new effort to re-examine the purpose of collecting, maintaining and providing access to generic Top-Level Domain (gTLD) registration data. The move follows the recommendations of a review team that examined implementation of WHOIS data policy.

Garth Bruen Discussing Whois, DNSSEC and Domain Security

NameSmash has interviewed Garth Bruen, Internet security expert and creator of Knujon, on some key issues under discussion during the recent ICANN meetings in San Francisco. Topics include Whois, DNS Security Extensions (DNSSEC) and generic Top-Level Domains (gTLDs) -- issues of critical importance particularly with ICANN's expected roll-out of thousands of new gTLDs in the coming years.

Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales

Garth Bruen reports on a paper published by the American Society of Law, Medicine & Ethics of Boston University School of Law authored by Bryan A. Liang and Tim Mackey titled, "Searching for Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales". From the paper: "Online sales of pharmaceuticals are a rapidly growing phenomenon. Yet despite the dangers of purchasing drugs over the Internet, sales continue to escalate. These dangers include patient harm from fake or tainted drugs, lack of clinical oversight, and financial loss. Patients, and in particular vulnerable groups such as seniors and minorities, purchase drugs online either naïvely or because they lack the ability to access medications from other sources due to price considerations. Unfortunately, high risk online drug sources dominate the Internet, and virtually no accountability exists to ensure safety of purchased products."